Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing. - Test2 - elhamkhani - TriplyDB

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

http://www.wikidata.org/entity/Q37489352

about

Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus HIV-1 functional cure: will the dream come true?Achieving HIV-1 Control through RNA-Directed Gene Regulation The varied roles of nuclear argonaute-small RNA complexes and avenues for therapy.Transcriptional gene silencing in humans.Promoter Targeting RNAs: Unexpected Contributors to the Control of HIV-1 Transcription.RNA interference approaches for treatment of HIV-1 infection Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing.The feasibility of incorporating Vpx into lentiviral gene therapy vectors.Gene therapy for HIV infection.Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations.Human immune cell targeting of protein nanoparticles--caveospheres.Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS.Mechanism of Interferon Stimulated Gene Induction in HIV-1 Infected Macrophages.HIV-1 CCR5 gene therapy will fail unless it is combined with a suicide gene.Towards a cure for human immunodeficiency virus.Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.Stable Transcriptional Repression and Parasitism of HIV-1.Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNA

P2860

Q26781275-7C3DD957-655C-46B9-9106-CF6805C4D898 Q26797870-42B88F4F-37EC-4831-98A6-C0494E91C9BF Q26865803-78F6D797-1A57-47ED-A2B0-B34E4FB155E5 Q28080090-67FE87FB-2F25-42E2-948C-F026030ACACB Q34440319-E9D63527-E6DD-4E54-B1B0-62A71A1744C6 Q34521385-08B571D2-046C-4DE6-BA83-D3E783D0B43C Q35133922-A4CF2E1B-D3D8-4817-96C1-7618F94BC86F Q35652119-6A627A2A-D6E6-4A30-A32A-F0D9DBF21D70 Q36939741-F6415E01-8015-4AA4-A943-DEDA4DB587F6 Q37350713-70824467-B147-4CA6-BB9B-575259ED3833 Q38260902-396C38ED-90E3-4E32-A635-72401BEBEE78 Q38288139-DB2E02B5-466D-45CB-9F8D-7F2B42C4FE83 Q38734072-0CBA12D3-7FE0-4750-9973-C0C3550DA53E Q38782237-CE2F7ACB-3A07-4F19-9661-99E3A418A039 Q38788187-95B025FB-517B-4594-9F86-C9F823A3AFA6 Q40097513-A004C4D0-F42C-49C2-BDCB-FD1E8301D7DC Q40205321-DD80577A-2A07-4B90-86BA-4D88A7132F75 Q47556728-AF0B7BC8-6067-4DD8-8EB5-D486C0BBF154 Q55343646-911B5F5F-8A78-4E3F-9193-5A02B975679D Q55399452-F363DAA4-2A6C-4EB0-BB0F-AF931C6B956C Q58800504-6D7641CF-AE81-4248-BA70-E8665C7F1104

P2860

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing.

http://www.wikidata.org/entity/Q37489352

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@en

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@nl

type

label

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@en

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@nl

prefLabel

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@en

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@nl

P1433

Q37489352-064E9672-FE6B-46E3-B724-48299749CADD

P1476

Q37489352-A7B465AD-7217-406F-8B66-C903666F7B2B

P2093

Q37489352-067523FE-BD67-4437-94BC-F724257D1496

Q37489352-308A9450-1521-43D1-A475-55263E19D59C

Q37489352-4B70880B-8EA2-4DED-BA84-84B407C7876F

Q37489352-567E2ED5-04F8-44ED-8D34-6F4468BD618A

Q37489352-7E4EF389-9A69-449E-BFD6-DE143595AE96

Q37489352-89A05039-A68E-4A84-B947-4E6A38A6F25C

Q37489352-8EAB24E4-B7CC-4754-A3FA-85BA3BF1FD85

Q37489352-B44A7EBB-B3D5-4907-A94D-13E2A8940A24

Q37489352-CA6A4E0B-A734-4BD7-8072-A7C22B199EE2

Q37489352-DDD43C94-A1B1-4081-8EB9-E6A6EEFE83F9

P2860

Q37489352-030B8586-BC59-4276-9B2F-A8C40B932246

Q37489352-05BF1DA4-893C-4B97-85CB-4969D2712ABF

Q37489352-0608110E-CF23-4137-8DD2-C896498F8781

Q37489352-103C2E15-5A05-4EC2-A052-99E19EEAE9C9

Q37489352-10AB24A3-13F2-4CFD-9405-94F9AF6B0E69

Q37489352-134B94A1-4EE6-416D-ADD0-3ED7BE33E772

Q37489352-15981493-9C98-4EA8-B4D2-02C152809305

Q37489352-1A4C6029-1B63-4330-B9BC-5E64348FBED4

Q37489352-23A74124-D59E-4981-9E6C-253DA174697B

Q37489352-23C6CF0C-E55B-446B-87F4-5FB808E9A3E5

P304

Q37489352-C070FA1E-2629-469F-8A81-6FFBC8708AE1

P31

Q37489352-D277DE31-80C6-4824-BB91-880A1606C313

P356

Q37489352-91F27400-74DF-4FC5-BCAE-A3AD40061C3F

P478

Q37489352-BBD40513-5E45-41D2-B848-4A1ED0B42A51

P50

Q37489352-6DC70FC3-11D0-44E7-A0F1-753C4DBC2435

P577

Q37489352-92D0DB7B-A718-4824-823A-CC4240AC58EB

P5875

Q37489352-AE876417-52EF-4849-B543-2B7DFEE1CCBB

P698

Q37489352-6001A667-BC6B-48D2-9AA5-BFAA4D2FED31

P921

Q37489352-1B4E992A-F4E3-4E69-B0BE-3AF7E73719BE

Q37489352-4A88E465-1D07-42A4-A822-9ADA25DC364A

P932

Q37489352-37C8E6BF-B3D8-435E-8A58-56B311048782

P356

P1433

Molecular therapy. Nucleic acids

P1476

Promoter Targeting shRNA Suppr ...... ranscriptional Gene Silencing.

@en

P2093

Anthony D Kelleher

http://www.w3.org/2001/XMLSchema#string

David A Cooper

http://www.w3.org/2001/XMLSchema#string

Geoff Symonds

http://www.w3.org/2001/XMLSchema#string

Katherine Marks

http://www.w3.org/2001/XMLSchema#string

Kazuo Suzuki

http://www.w3.org/2001/XMLSchema#string

Maureen Boyd

http://www.w3.org/2001/XMLSchema#string

Michelle Millington

http://www.w3.org/2001/XMLSchema#string

Seiji Okada

http://www.w3.org/2001/XMLSchema#string

Shinichiro Hattori

http://www.w3.org/2001/XMLSchema#string

Takaomi Ishida

http://www.w3.org/2001/XMLSchema#string

P2860

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

An RNA targeted to the HIV-1 LTR promoter modulates indiscriminate off-target gene activation

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome

A system for stable expression of short interfering RNAs in mammalian cells

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Transcriptional gene silencing through epigenetic changes mediated by non-coding RNAs

Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Expression profiling reveals off-target gene regulation by RNAi

P304

e137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MTNA.2013.64

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Chantelle Ahlenstiel

P577

2013-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259154863

http://www.w3.org/2001/XMLSchema#string

P698

24301868

http://www.w3.org/2001/XMLSchema#string

P921

P932

3894581

http://www.w3.org/2001/XMLSchema#string